Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Lorens
S A
SA
Department of Pharmacology, Loyola University Medical Center, Maywood, IL 60153.
Hata
N
N
Cabrera
T
T
Hamilton
M E
ME
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology*; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D001143:Arousal / Q000187:drug effects*; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects*; D015198:Designer Drugs; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D005277:Fenfluramine / Q000494:pharmacology*; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism
D000662:Amphetamines; D015198:Designer Drugs; D004102:Dihydroxytryptamines; D011985:Receptors, Serotonin; D005277:Fenfluramine; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine